Shares of Swiss medical holding company Sonova (SOON.CH) are declining nearly 8% and slipping below key support as the company announced the loss of a major U.S. customer, which could hit its financial results in at least the first half of the year. Also Q1 results were mixed. However, Sonova didn't disclose the name of given US company:
- Analysts at JP Morgan, Jefferies and Vontobel indicated that the frm that Sonova does not want to disclose is one of the largest US wholesalers Costco (COST.US). Sonova's management conveyed in a statement that results were solid but not enough to dampen market sentiment;
- Pre-tax profit was CHF 840.4 million in Q1 2023, which beat analysts' forecast of CHF 859.7 million in a Vara Research survey. At the same time, however, Q1 sales rose 14.6%, below expectations of 15%-19%, suggesting that inflation is curbing demand for the company's equipment and services;
- Sonova said, however, that it still expects consolidated sales to grow 3%-7% in 2023-2024, and adjusted pre-tax profit excluding currency factors to rise in the 6%-10% range,
- In an interview with Reuteres, a Sonova spokesman indicated that the loss of a U.S. trading partner will be a hurdle in the first half of the year. The company is keeping a close eye on consumer trends in a challenging economic environment;
- The commentary on the results also read that full-year profit will likely be below expectations, and that it may take longer to return to the pace of robust growth given the loss of a customer in the US and inflation. This information did not please investors. If the loss of the Costco contract is confirmed - it could cost the company a significant reduction in revenue from the US market.
Sonova (SOON.CH) shares, W1 interval. The stock price was at January 2020 levels, just before the Covidian meltdown that hit demand for its services and products. The stock has settled below the SMA200 (red line) signaling that a test of trend strength around the 61.8 and 71.6 Fibonacci restracement is still possible. If the support set by the 2020 price reaction does not hold, a test of CHF240 per share will become realistic. Source: xStation5.
Kezdjen befektetni még ma, vagy próbålja ki ingyenes demónkat
ĂlĆ szĂĄmla regisztrĂĄciĂł DEMĂ SZĂMLA Mobil app letöltĂ©se Mobil app letöltĂ©seEzen tartalmat az XTB S.A. kĂ©szĂtette, amelynek szĂ©khelye VarsĂłban talĂĄlhatĂł a következĆ cĂmen, Prosta 67, 00-838 VarsĂł, LengyelorszĂĄg (KRS szĂĄm: 0000217580), Ă©s a lengyel pĂ©nzĂŒgyi hatĂłsĂĄg (KNF) felĂŒgyeli (sz. DDM-M-4021-57-1/2005). Ezen tartalom a 2014/65/EU irĂĄnyelvĂ©nek, ami az EurĂłpai Parlament Ă©s a TanĂĄcs 2014. mĂĄjus 15-i hatĂĄrozata a pĂ©nzĂŒgyi eszközök piacairĂłl , 24. cikkĂ©nek (3) bekezdĂ©se , valamint a 2002/92 / EK irĂĄnyelv Ă©s a 2011/61 / EU irĂĄnyelv (MiFID II) szerint marketingkommunikĂĄciĂłnak minĆsĂŒl, tovĂĄbbĂĄ nem minĆsĂŒl befektetĂ©si tanĂĄcsadĂĄsnak vagy befektetĂ©si kutatĂĄsnak. A marketingkommunikĂĄciĂł nem befektetĂ©si ajĂĄnlĂĄs vagy informĂĄciĂł, amely befektetĂ©si stratĂ©giĂĄt javasol a következĆ rendeleteknek megfelelĆen, Az EurĂłpai Parlament Ă©s a TanĂĄcs 596/2014 / EU rendelete (2014. ĂĄprilis 16.) a piaci visszaĂ©lĂ©sekrĆl (a piaci visszaĂ©lĂ©sekrĆl szĂłlĂł rendelet), valamint a 2003/6 / EK eurĂłpai parlamenti Ă©s tanĂĄcsi irĂĄnyelv Ă©s a 2003/124 / EK bizottsĂĄgi irĂĄnyelvek hatĂĄlyon kĂvĂŒl helyezĂ©sĂ©rĆl / EK, 2003/125 / EK Ă©s 2004/72 / EK, valamint az (EU) 2016/958 bizottsĂĄgi felhatalmazĂĄson alapulĂł rendelet (2016. mĂĄrcius 9.) az 596/2014 / EU eurĂłpai parlamenti Ă©s tanĂĄcsi rendeletnek a szabĂĄlyozĂĄsi technikai szabĂĄlyozĂĄs tekintetĂ©ben törtĂ©nĆ kiegĂ©szĂtĂ©sĂ©rĆl a befektetĂ©si ajĂĄnlĂĄsok vagy a befektetĂ©si stratĂ©giĂĄt javaslĂł vagy javaslĂł egyĂ©b informĂĄciĂłk objektĂv bemutatĂĄsĂĄra, valamint az egyes Ă©rdekek vagy összefĂ©rhetetlensĂ©g utĂĄni jelek nyilvĂĄnossĂĄgra hozatalĂĄnak technikai szabĂĄlyaira vonatkozĂł szabvĂĄnyok vagy egyĂ©b tanĂĄcsadĂĄs, ideĂ©rtve a befektetĂ©si tanĂĄcsadĂĄst is, az A pĂ©nzĂŒgyi eszközök kereskedelmĂ©rĆl szĂłlĂł, 2005. jĂșlius 29-i törvĂ©ny (azaz a 2019. Ă©vi Lap, mĂłdosĂtott 875 tĂ©tel). Ezen marketingkommunikĂĄciĂł a legnagyobb gondossĂĄggal, tĂĄrgyilagossĂĄggal kĂ©szĂŒlt, bemutatja azokat a tĂ©nyeket, amelyek a szerzĆ szĂĄmĂĄra a kĂ©szĂtĂ©s idĆpontjĂĄban ismertek voltak , valamint mindenfĂ©le Ă©rtĂ©kelĂ©si elemtĆl mentes. A marketingkommunikĂĄciĂł az ĂgyfĂ©l igĂ©nyeinek, az egyĂ©ni pĂ©nzĂŒgyi helyzetĂ©nek figyelembevĂ©tele nĂ©lkĂŒl kĂ©szĂŒl, Ă©s semmilyen mĂłdon nem terjeszt elĆ befektetĂ©si stratĂ©giĂĄt. A marketingkommunikĂĄciĂł nem minĆsĂŒl semmilyen pĂ©nzĂŒgyi eszköz eladĂĄsi, felajĂĄnlĂĄsi, feliratkozĂĄsi, vĂĄsĂĄrlĂĄsi felhĂvĂĄsĂĄnak, hirdetĂ©sĂ©nek vagy promĂłciĂłjĂĄnak. Az XTB S.A. nem vĂĄllal felelĆssĂ©get az ĂgyfĂ©l ezen marketingkommunikĂĄciĂłban foglalt informĂĄciĂłk alapjĂĄn tett cselekedeteiĂ©rt vagy mulasztĂĄsaiĂ©rt, kĂŒlönösen a pĂ©nzĂŒgyi eszközök megszerzĂ©sĂ©Ă©rt vagy elidegenĂtĂ©sĂ©Ă©rt. Abban az esetben, ha a marketingkommunikĂĄciĂł bĂĄrmilyen informĂĄciĂłt tartalmaz az abban megjelölt pĂ©nzĂŒgyi eszközökkel kapcsolatos eredmĂ©nyekrĆl, azok nem jelentenek garanciĂĄt vagy elĆrejelzĂ©st a jövĆbeli eredmĂ©nyekkel kapcsolatban.
